Literature DB >> 11159772

Immunofluorometric assay of human kallikrein 10 and its identification in biological fluids and tissues.

L Y Luo1, L Grass, D J Howarth, P Thibault, H Ong, E P Diamandis.   

Abstract

BACKGROUND: The human kallikrein 10 gene [KLK10, also known as normal epithelial cell-specific 1 gene (NES1)] is a member of the human kallikrein gene family. The KLK10 gene encodes for a secreted serine protease (hK10). We hypothesize that hK10 is secreted into various biological fluids and that its concentration changes in some disease states. The aim of this study was to develop a sensitive and specific immunoassay for hK10.
METHODS: Recombinant hK10 protein was produced and purified using a Pichia pastoris yeast expression system. The protein was used as an immunogen to generate mouse and rabbit polyclonal anti-hK10 antisera. A sandwich-type immunofluorometric assay was then developed using these antibodies.
RESULTS: The hK10 immunoassay has a detection limit of 0.05 microg/L. The assay is specific for hK10 and has no detectable cross-reactivity with other homologous kallikrein proteins, such as prostate-specific antigen (hK3), human glandular kallikrein 2 (hK2), and human kallikrein 6 (hK6). The assay was linear from 0 to 20 microg/L with within- and between-run CVs <10%. hK10 is expressed in many tissues, including the salivary glands, skin, and colon and is also detectable in biological fluids, including breast milk, seminal plasma, cerebrospinal fluid, amniotic fluid, and serum.
CONCLUSIONS: We report development of the first immunofluorometric assay for hK10 and describe the distribution of hK10 in biological fluids and tissue extracts. This assay can be used to examine the value of hK10 as a disease biomarker.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159772

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  10 in total

1.  Expression analysis and clinical evaluation of kallikrein-related peptidase 10 (KLK10) in colorectal cancer.

Authors:  Maroulio Talieri; Dimitra K Alexopoulou; Andreas Scorilas; Dimitris Kypraios; Niki Arnogiannaki; Marina Devetzi; Matina Patsavela; Dimitris Xynopoulos
Journal:  Tumour Biol       Date:  2011-04-12

Review 2.  Emerging Proteins in CRPC: Functional Roles and Clinical Implications.

Authors:  Piaoping Kong; Lingyu Zhang; Zhengliang Zhang; Kangle Feng; Yiwen Sang; Xiuzhi Duan; Chunhua Liu; Tao Sun; Zhihua Tao; Weiwei Liu
Journal:  Front Oncol       Date:  2022-06-10       Impact factor: 5.738

3.  Kallikreins 5, 6 and 10 differentially alter pathophysiology and overall survival in an ovarian cancer xenograft model.

Authors:  David Pépin; Zhong-Qi Shao; Geneviève Huppé; Andrea Wakefield; Chee-Wui Chu; Zahra Sharif; Barbara C Vanderhyden
Journal:  PLoS One       Date:  2011-11-15       Impact factor: 3.240

4.  A new enzyme-linked immunosorbent assay (ELISA) for human free and bound kallikrein 9.

Authors:  Panagiota Filippou; Dimitrios Korbakis; Sofia Farkona; Antoninus Soosaipillai; Theano Karakosta; Eleftherios P Diamandis
Journal:  Clin Proteomics       Date:  2017-01-17       Impact factor: 3.988

5.  Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer's disease and associated with CSF-TAU and FDG-PET.

Authors:  Oliver Goldhardt; Inanna Warnhoff; Igor Yakushev; Ilijana Begcevic; Hans Förstl; Viktor Magdolen; Antoninus Soosaipillai; Eleftherios Diamandis; Panagiotis Alexopoulos; Timo Grimmer
Journal:  Transl Neurodegener       Date:  2019-08-27       Impact factor: 8.014

6.  Kallikrein gene downregulation in breast cancer.

Authors:  G M Yousef; G M Yacoub; M-E Polymeris; C Popalis; A Soosaipillai; E P Diamandis
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

7.  Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance.

Authors:  L-Y Luo; E P Diamandis; M P Look; A P Soosaipillai; J A Foekens
Journal:  Br J Cancer       Date:  2002-06-05       Impact factor: 7.640

8.  Gene-specific DNA methylation association with serum levels of C-reactive protein in African Americans.

Authors:  Yan V Sun; Alicia Lazarus; Jennifer A Smith; Yu-Hsuan Chuang; Wei Zhao; Stephen T Turner; Sharon L R Kardia
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

9.  NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells.

Authors:  Jiajia Hu; Hu Lei; Xiaochun Fei; Sheng Liang; Hanzhang Xu; Dongjun Qin; Yue Wang; Yingli Wu; Biao Li
Journal:  Sci Rep       Date:  2015-11-30       Impact factor: 4.379

10.  Structural basis for the Zn2+ inhibition of the zymogen-like kallikrein-related peptidase 10.

Authors:  Mekdes Debela; Viktor Magdolen; Wolfram Bode; Hans Brandstetter; Peter Goettig
Journal:  Biol Chem       Date:  2016-12-01       Impact factor: 3.915

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.